HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

2,5-di-tert-butylhydroquinone

Ca2+-ATPase antagonist
Also Known As:
2,5-di(tert-butyl)-1,4-benzohydroquinone; 2,5-di-t-butylquinol; DTBHQ; tBuBHQ
Networked: 6 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Shieh, Pochuen: 1 article (10/2013)
2. Chou, Chiang-Ting: 1 article (10/2013)
3. Jan, Chung-Ren: 1 article (10/2013)
4. Huang, Jong-Khing: 1 article (10/2013)
5. Chen, I-Li: 1 article (10/2013)
6. Kuo, Daih-Huang: 1 article (10/2013)
7. Liang, Wei-Zhe: 1 article (10/2013)
8. Chang, Hong-Tai: 1 article (10/2013)
9. Mitsumori, K: 1 article (02/2000)
10. Takahashi, M: 1 article (02/2000)

Related Diseases

1. Muscle Weakness
2. Neoplasms (Cancer)
3. Leukemia
4. Glioma (Gliomas)
5. Diarrhea

Related Drugs and Biologics

1. Neurocalcin
2. Type C Phospholipases
3. 1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dione
4. resveratrol
5. Thapsigargin
6. Thimerosal (Thiomersal)
7. Staphylococcal Protein A (A, Protein)
8. Phosphotransferases (Kinase)
9. Calcium
10. Antigens

Related Therapies and Procedures

1. Oral Administration